PDB15 A COST-EFFECTIVENESS ANALYSIS OF SWITCHING TYPE-2 DIABETES PATIENTS FROM IMMEDIATE-RELEASE METFORMIN (GLUCOPHAGE) TO A NEW EXTENDEDRELEASE FORMULATION OF METFORMIN (GLUCOPHAGEXR)

Nov 1, 2004, 00:00 AM
10.1016/S1098-3015(10)65958-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65958-X/fulltext
Section Title :
Section Order : 324
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65958-X&doi=10.1016/S1098-3015(10)65958-X
HEOR Topics :
Tags :
Regions :